BIO-key International, Inc.
BKYI
$0.7801
$0.03114.15%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.29M | 6.96M | 7.75M | 7.75M | 7.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.29M | 6.96M | 7.75M | 7.75M | 7.69M |
| Cost of Revenue | 2.95M | 3.96M | 5.30M | 6.32M | 5.39M |
| Gross Profit | 4.34M | 3.01M | 2.45M | 1.43M | 2.30M |
| SG&A Expenses | 7.37M | 7.54M | 7.74M | 7.89M | 8.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.76M | 13.82M | 15.33M | 16.58M | 16.90M |
| Operating Income | -5.47M | -6.85M | -7.58M | -8.83M | -9.21M |
| Income Before Tax | -5.57M | -6.66M | -7.48M | -8.66M | -12.82M |
| Income Tax Expenses | -276.80K | -277.00K | -134.00K | -134.00K | 122.40K |
| Earnings from Continuing Operations | -5.29 | -6.39 | -7.34 | -8.52 | -12.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.29M | -6.39M | -7.34M | -8.52M | -12.94M |
| EBIT | -5.47M | -6.85M | -7.58M | -8.83M | -9.21M |
| EBITDA | -8.79M | -10.21M | -10.94M | -12.20M | -8.86M |
| EPS Basic | -5.94 | -8.77 | -12.48 | -15.68 | -26.29 |
| Normalized Basic EPS | -1.07 | -3.02 | -5.13 | -7.31 | -13.14 |
| EPS Diluted | -5.94 | -8.77 | -12.48 | -15.68 | -26.29 |
| Normalized Diluted EPS | -1.07 | -3.02 | -5.13 | -7.31 | -13.14 |
| Average Basic Shares Outstanding | 5.73M | 4.41M | 3.30M | 2.17M | 2.07M |
| Average Diluted Shares Outstanding | 5.73M | 4.41M | 3.30M | 2.17M | 2.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |